Search

everythinglearnresearchcommunity

for

Search:↓

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Most types of hair loss can regrow naturally, but there are no effective cures for male pattern or age-related hair loss, and only limited options for females.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Plant-derived nanoparticles from Polygoni Multiflori Radix promote hair growth better than Minoxidil by affecting androgen pathways.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Targeting CXCL12 may help treat hair loss caused by androgens.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

ERG increases SOX9, promoting prostate cancer growth and invasion.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Male pattern baldness involves genetics, hormones, and needs better treatments.